Dr. Alfredo Quijano

AI-based design of proteins for health applications

Speaker: Dr. Alfredo Quijano
Institution: University of Washington (Seattle)

Place: Jerónimo Forteza conference room, CIPF

Abstract: Dr. Alfredo Quijano is a young Valencian scientist who performed his PhD in the USA via a fellowship from La Caixa. The director of his thesis at the University of Washington (Seattle) is none other than Dr. David Baker, recipient of the Nobel Prize in Chemistry 2024! (The Baker Lab develops protein design software to create molecules that solve challenges in medicine, technology, and sustainability.) After completing his PhD, Alfredo and a colleague started the biotech Monod (see link below) in 2022 dedicated to using AI to design proteins for both research and clinical applications. Their technology is being used, for example, to make improvements to luciferase assays and to develop molecular biosensors that light up when they bind their target. The potential for this use of AI is enormous, particularly for disease applications.

Home

Sponsored by:

With support from Generalitat Valenciana, AMPER-07/2024 and CIAORG/2023/147